Sinonasal quality of life in primary ciliary dyskinesia
- 25 May 2023
- journal article
- research article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 13 (11) , 2101-2104
Abstract
Key points: Our findings suggest that primary ciliary dyskinesia (PCD)‐related chronic rhinosinusitis (CRS) has a more significant impact on quality of life than CRS without nasal polyps and cystic fibrosis (CF). PCD and CF have similar mucociliary clearance defects, yet sinonasal symptom severity varies between the two.Keywords
Funding Information
- National Institutes of Health (KL2TR002490, U54HL096458, 5T32DC005360‐19)
This publication has 8 references indexed in Scilit:
- Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosisJournal of Cystic Fibrosis, 2022
- Olfactory dysfunction in cystic fibrosis: Impact of CFTR modulator therapyJournal of Cystic Fibrosis, 2022
- Chronic rhinosinusitis in cystic fibrosis: a review of therapeutic optionsEuropean Archives of Oto-Rhino-Laryngology, 2021
- Sinus Development and Pneumatization in a Primary Ciliary Dyskinesia CohortAmerican Journal of Rhinology & Allergy, 2020
- Chronic rhinosinusitis in patients with cystic fibrosis—Current management and new treatmentsLaryngoscope Investigative Otolaryngology, 2020
- Olfactory dysfunction is worse in primary ciliary dyskinesia compared with other causes of chronic sinusitis in childrenThorax, 2018
- Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art reviewPediatric Pulmonology, 2015
- The Development of the Rhinosinusitis Disability IndexJAMA Otolaryngology–Head & Neck Surgery, 1997